Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate
G.J.D. Hengstman(Radboud University Nijmegen), F.H.J. van den Hoogen, Hanne Jensen(Gentofte Hospital), Eugen Feist(Charité - Universitätsmedizin Berlin), John Vissing(University of Copenhagen), CP Denton(The Royal Free Hospital), Jan De Bleecker(Ghent University Hospital), Baziel G.M. van Engelen(Radboud University Nijmegen), M. N. Manoussakis(National and Kapodistrian University of Athens)
Cited by 99
Related Papers
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
|The Lancet Neurology|2017|820
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
|Neuromuscular Disorders|2019|308